eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | rheumatoid arthritis |
| Comorbidity | C0007222|cardiovascular disease |
| Sentences | 63 |
| PubMedID- 25011482 | Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 25026799 | [cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy]. |
| PubMedID- 23584985 | Novel risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 21180241 | Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23193471 | cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. |
| PubMedID- 23818136 | Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score [frs]). |
| PubMedID- 26082375 | [pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis]. |
| PubMedID- 26023546 | Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis. |
| PubMedID- 20164773 | cardiovascular disease in rheumatoid arthritis: a step forward. |
| PubMedID- 20868308 | Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd). |
| PubMedID- 21846359 | Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. |
| PubMedID- 23666917 | Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte). |
| PubMedID- 24498229 | Objective: to evaluate the risk of cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids. |
| PubMedID- 22935383 | Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown. |
| PubMedID- 22360682 | Lack of association between tlr4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23244227 | cardiovascular diseases in patients with rheumatoid arthritis. |
| PubMedID- 20827876 | cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. |
| PubMedID- 23300117 | Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward). |
| PubMedID- 24874661 | Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis. |
| PubMedID- 22337246 | Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23256829 | The risk of cardiovascular disease associated with rheumatoid arthritis equals that of diabetes mellitus. |
| PubMedID- 23079082 | Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations. |
| PubMedID- 21520672 | [excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause. |
| PubMedID- 26362702 | Objective: to identify risk factors for cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 21109513 | cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. |
| PubMedID- 21269581 | Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21073447 | To assess the potential association between adipoq rs266729 and rs1501299 gene polymorphisms, either isolated or in combination, and cardiovascular disease in patients with rheumatoid arthritis (ra), 674 patients seen at the rheumatology outpatient clinics of hospital xeral-calde, lugo, and hospital san carlos, madrid, spain, were analyzed. |
| PubMedID- 21981268 | Lack of association of il6r rs2228145 and il6st/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22521305 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21071477 | Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. |
| PubMedID- 21385539 | Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21345288 | Lack of association between retn rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 24795506 | Lack of association between abo, ppap2b, adamst7, pik3cg, and ednra and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20383550 | Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 20735865 | Palomino-morales and colleagues [1] report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra). |
| PubMedID- 21276397 | [excess mortality from cardiovascular disease in patients with rheumatoid arthritis]. |
| PubMedID- 22808986 | Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 24498997 | Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21411091 | Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. |
| PubMedID- 23749610 | Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. |
| PubMedID- 22657383 | Association of the methionine sulfoxide reductase a rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22337612 | Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 25969671 | Several epidemiological studies reported increased morbidity and mortality from cardiovascular diseases in patients with rheumatoid arthritis [2], and strong evidences from basic research and epidemiological studies support that inflammation and venous thrombosis are associated processes [3]. |
| PubMedID- 25754335 | rheumatoid arthritis (ra) associates with increased cardiovascular disease (cvd) mortality thought to be due to accelerated arterial disease. |
| PubMedID- 20842919 | [cardiovascular diseases in rheumatoid arthritis]. |
| PubMedID- 24511540 | Suggests that vegfa polymorphisms do not seem to exert a significant influence on the risk of cardiovascular disease in patients with rheumatoid arthritis [6]. |
| PubMedID- 22272574 | Influence of mhciita rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. |
| PubMedID- 22927710 | Genetic markers of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 22284683 | We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21420089 | Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. |
Page: 1 2